Addressing the Challenges of CNS Drug Delivery

Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....

5 years ago
Biology

Addressing the Challenges of CNS Drug Delivery

Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....

5 years ago

The Latest Advancements in Immuno-oncology: Checkpoint Inhibitors

Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...

5 years ago
Oncology,Biology,News

The Latest Advancements in Immuno-oncology: Checkpoint Inhibitors

Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...

5 years ago

Building a FAIR Culture in Pharma

The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...

5 years ago
R&D,Bioinformatics,Data,News

Building a FAIR Culture in Pharma

The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...

5 years ago

Utilising Machine Learning in Drug Discovery: Opportunities and Challenges

From artificial neural networks to predictive modelling, artificial intelligence (AI) is making its mark in the pharmaceutical industry. The ever-increasing cost of development, shorter timelines and rise in demand has seen the industry reach out to AI to help bring...

5 years ago
R&D,AI & ML,News

Utilising Machine Learning in Drug Discovery: Opportunities and Challenges

From artificial neural networks to predictive modelling, artificial intelligence (AI) is making its mark in the pharmaceutical industry. The ever-increasing cost of development, shorter timelines and rise in demand has seen the industry reach out to AI to help bring...

5 years ago

Emisphere’s Stockholders Sue Over Novo Nordisk Purchase

For daily articles on the latest pharma trends and innovations, as well as interviews with leading experts and in-depth industry White Papers, subscribe to PharmaFeatures.com. A trio of lawsuits are being levelled at Emisphere Technologies over its recent sale to Novo...

5 years ago
Investment,News

Emisphere’s Stockholders Sue Over Novo Nordisk Purchase

For daily articles on the latest pharma trends and innovations, as well as interviews with leading experts and in-depth industry White Papers, subscribe to PharmaFeatures.com. A trio of lawsuits are being levelled at Emisphere Technologies over its recent sale to Novo...

5 years ago

The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu

Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...

5 years ago
R&D,Precision and Personalised Medicine,Biology,News

The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu

Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...

5 years ago
Previous Page Showing 174 out of 323 Next Page
Working With us

Interested?
Reserve your space